Terns Pharmaceuticals Inc TERN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
5.99UNCH (UNCH)
Volume
17,288
Close
5.99quote price arrow up+0.10 (+1.70%)
Volume
844,726
52 week range
3.26 - 13.23
Loading...
  • Open6.00
  • Day High6.12
  • Day Low5.88
  • Prev Close5.89
  • 52 Week High13.23
  • 52 Week High Date05/15/23
  • 52 Week Low3.26
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap387.402M
  • Shares Out64.67M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta-0.51
  • YTD % Change-7.7

KEY STATS

  • Open6.00
  • Day High6.12
  • Day Low5.88
  • Prev Close5.89
  • 52 Week High13.23
  • 52 Week High Date05/15/23
  • 52 Week Low3.26
  • 52 Week Low Date11/10/23
  • Market Cap387.402M
  • Shares Out64.67M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta-0.51
  • YTD % Change-7.7

RATIOS/PROFITABILITY

  • EPS (TTM)-1.26
  • P/E (TTM)-4.76
  • Fwd P/E (NTM)-4.42
  • EBITDA (TTM)-102.266M
  • ROE (TTM)-33.89%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,877.10%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Terns Pharmaceuticals Inc

 

Profile

MORE
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Its pipeline includes three clinical-stage development programs: TERN-701, TERN-601 and TERN-501. TERN-701 is its oral, potent, allosteric BCR-ABL tyrosine kinase inhibitors (TKI) specifically targeting the ABL myristoyl pocket for CML, a form of cancer that...
David Fellows
Independent Chairman of the Board
Amy Burroughs
Chief Executive Officer, Director
Erin Quirk M.D.
President, Head of Research & Development
Bryan Yoon Esq.
Chief Operating Officer, General Counsel, Secretary
Mark Vignola Ph.D.
Chief Financial Officer, Treasurer
Address
1065 East Hillsdale Blvd.
Suite 100, Suite 100
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
AURA
Aura Biosciences Inc
7.53+0.35+4.87%
ADVM
Adverum Biotechnologies Inc
8.93-0.24-2.62%
TRML
Tourmaline Bio Inc
14.42-0.02-0.14%
NAUT
Nautilus Biotechnology Inc
2.86+0.13+4.76%
BMEA
Biomea Fusion Inc
12.37+0.92+8.03%